Japanese pharma firms turn to CDMOs early as peptide complexity rises
Neuland Laboratories reported an uptick in peptide-related engagements from Japanese companies, particularly at the preclinical and early clinical stages
Neuland Laboratories reported an uptick in peptide-related engagements from Japanese companies, particularly at the preclinical and early clinical stages
The product is approved as bioequivalent to Xigduo XR for the indications outlined in the reference drug’s labelling
The system is powered by BrainSense technology, which has received approval from USFDA
C. P. Radhakrishnan urged graduates to uphold ethical standards and maintain a commitment to patient care
CLIRNET plans to expand globally and improve how medical knowledge is shared and used in practice
Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations
A decision is expected by August 17, 2026 under the Prescription Drug User Fee Act timeline
C-CAMP–Imperial College London partnership to boost biotech research, startup exchange, and translational innovation through a five-year collaboration
The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems
These findings help explain how relapse-triggering memories can persist alongside those that support recovery
Subscribe To Our Newsletter & Stay Updated